BioCentury | Apr 22, 2017
Finance

Sweden heating up

...continue through year end according to local VCs and bankers. Cancer and metabolic disease company Sprint Bioscience AB...
BioCentury | Jul 25, 2016
Company News

Sprint Bioscience deal

...funding for one year, with an option to extend. Sprint did not respond to inquiries. Sprint Bioscience AB...
BioCentury | Oct 22, 2012
Emerging Company Profile

Sprint: Quick start in cancer

...Palo Alto, Calif. Sprint Bioscience AB , Stockholm, Sweden Swedish Orphan Biovitrum AB (SSE:SOBI), Stockholm, Sweden Sidebars Sprint Bioscience AB...
BioCentury | Oct 15, 2012
Financial News

Sprint Bioscience completes venture financing

Sprint Bioscience AB , Stockholm, Sweden Business: Cancer Date completed: 10/8/12 Type: Venture financing Raised: $600,000 Investors: Forsta Entreprenorsfonden; Almi Invest WIR Staff...
BioCentury | Oct 27, 2011
Targets & Mechanisms

Taking down autophagy

...lack of high-quality tool compounds with well-established mechanisms of action," said Anders Åberg, CEO of Sprint Bioscience AB...
...Cambridge, Mass. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Shanghai Institute of Organic Chemistry , Shanghai, China Sprint Bioscience AB...
Items per page:
1 - 5 of 5
BioCentury | Apr 22, 2017
Finance

Sweden heating up

...continue through year end according to local VCs and bankers. Cancer and metabolic disease company Sprint Bioscience AB...
BioCentury | Jul 25, 2016
Company News

Sprint Bioscience deal

...funding for one year, with an option to extend. Sprint did not respond to inquiries. Sprint Bioscience AB...
BioCentury | Oct 22, 2012
Emerging Company Profile

Sprint: Quick start in cancer

...Palo Alto, Calif. Sprint Bioscience AB , Stockholm, Sweden Swedish Orphan Biovitrum AB (SSE:SOBI), Stockholm, Sweden Sidebars Sprint Bioscience AB...
BioCentury | Oct 15, 2012
Financial News

Sprint Bioscience completes venture financing

Sprint Bioscience AB , Stockholm, Sweden Business: Cancer Date completed: 10/8/12 Type: Venture financing Raised: $600,000 Investors: Forsta Entreprenorsfonden; Almi Invest WIR Staff...
BioCentury | Oct 27, 2011
Targets & Mechanisms

Taking down autophagy

...lack of high-quality tool compounds with well-established mechanisms of action," said Anders Åberg, CEO of Sprint Bioscience AB...
...Cambridge, Mass. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Shanghai Institute of Organic Chemistry , Shanghai, China Sprint Bioscience AB...
Items per page:
1 - 5 of 5